DENTSPLY SIRONA Inc. 10-Q

Item 2 – Unregistered Sales of Securities and Use of Proceeds During the three months ended March 31, 2022, the Company had the following activity with respect to this repurchase program: (in millions, except per share amounts) Total Number of Shares Purchased Average Price Paid Per Share Total Cost of Shares Purchased Dollar Value of Shares that May be Purchased Under the Stock Repurchase Program Period January 1, 2022 to January 31, 2022 — $ — $ — $ 890 February 1, 2022 to February 28, 2022 — — — 890 March 1, 2022 to March 31, 2022 2.4 50.44 120 770 2.4 $ 50.44 $ 120 $ 770 (a) On July 28, 2021 the Board of Directors approved a share repurchase program, up to $1.0 billion. On March 8, 2022, the Company entered into an ASR Agreement with a financial institution, to repurchase $150 million of the Company’s common stock. For further information on the ASR Agreement see Part I, Item 1, Note 5, Earnings Per Common Share, in the Notes to Unaudited Interim Consolidated Financial Statements of this Form 10-Q. 49 Item 6 – Exhibits Exhibit Number Description 31.1 Section 302 Certification Statement Chief Executive Officer 31.2 Section 302 Certification Statement Chief Financial Officer 32 Section 906 Certification Statements 101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. 101.SCH XBRL Taxonomy Extension Schema Document 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF XBRL Taxonomy Extension Definition Linkbase Document 101.LAB XBRL Extension Labels Linkbase Document 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) 50 Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DENTSPLY SIRONA Inc. /s/ Simon D. Campion November 7, 2022 Simon D. Campion Date Chief Executive Officer /s/ Glenn G. Coleman November 7, 2022 Glenn G. Coleman Date Chief Financial Officer 51